MTOR and mesothelioma: The protein kinase mammalian target of rapamycin (mTOR) is involved in the regulation of several processes, including cell proliferation, autophagy and apoptosis, and its aberrant activation in mesothelioma makes it a potential therapeutic target for this tumor [60,61].